Showing results (1-10 of 336) with videos related to
Sort By:
Pageof 34
Blood Advances|November 27, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M ConnorsCancers|August 17, 2018
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated ThrombosisHanny Al-Samkari, Jean M ConnorsHematology. American Society of Hematology. Education Program|December 7, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M ConnorsCancers|July 26, 2020
Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer PatientsOrly Leiva, Jean M Connors, Hanny Al-SamkariJournal of Thrombosis and Thrombolysis|March 23, 2018
Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpuraHanny Al-Samkari, Rachael F Grace, Jean M ConnorsCurrent Opinion in Cardiology|August 8, 2019
Thrombophilia evaluation in pulmonary embolismRobert M Stern, Hanny Al-Samkari, Jean M ConnorsVascular Health and Risk Management|August 17, 2019
Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patientsAndrew B Song, Rachel P Rosovsky, Jean M Connors, et al.Seminars in Thrombosis and Hemostasis|February 28, 2022
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for CliniciansHanny Al-SamkariHematology. American Society of Hematology. Education Program|December 9, 2022
Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problemHanny Al-SamkariPageof 34